rs369915689
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000361114.10(MICU1):c.735+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000188 in 1,540,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
ENST00000361114.10 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MICU1 | NM_001195518.2 | c.735+1G>A | splice_donor_variant | ENST00000361114.10 | NP_001182447.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MICU1 | ENST00000361114.10 | c.735+1G>A | splice_donor_variant | 1 | NM_001195518.2 | ENSP00000354415 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000548 AC: 8AN: 146006Hom.: 0 AF XY: 0.0000260 AC XY: 2AN XY: 77010
GnomAD4 exome AF: 0.0000187 AC: 26AN: 1388194Hom.: 0 Cov.: 29 AF XY: 0.0000131 AC XY: 9AN XY: 684600
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74324
ClinVar
Submissions by phenotype
not provided Pathogenic:6
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2023 | This sequence change affects a donor splice site in intron 8 of the MICU1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs369915689, gnomAD 0.01%). Disruption of this splice site has been observed in individuals with clinical features of myopathy with extrapyramidal signs (PMID: 24336167). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 101046). Studies have shown that disruption of this splice site results in retention of 155 bp of intron 8 and introduces a premature termination codon (PMID: 24336167). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 24, 2023 | Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24336167, 33386810) - |
Proximal myopathy with extrapyramidal signs Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Clinical Exome/Genome Diagnostics Group, University Hospital Bonn | May 23, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Jun 08, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 16, 2020 | The c.741+1G>A variant in MICU1 has been reported in the homozygous state in 2 sibling pairs with proximal myopathy with extrapyramidal signs from unrelated Dutch families (Logan 2014 PMID: 24336167). It has also been reported in ClinVar (Variation ID 101046) and has been identified in 0.01% (9/73090) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant occurs within the canonical splice site (+/- 1,2) and in vitro functional studies using patient mRNA have shown that this variant affects splicing and leads to markedly decreased MICU1 mRNA and loss of protein levels (Logan 2014 PMID: 24336167). Loss of function variants, including splice variants, have been reported in individuals with proximal myopathy with extrapyramidal signs. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive proximal myopathy with extrapyramidal signs. ACMG/AMP Criteria applied: PVS1, PM3_Supporting, PP1. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at